The Director of Marketing will lead U.S. HCP marketing strategy and execution to support the launch of rezatapopt. They will collaborate with cross-functional teams to drive customer engagement, educational initiatives, and promotional programs.
The Executive Director of Biostatistics will lead the biostatistics function, setting statistical strategy for clinical programs and managing the internal team. This role serves as the primary statistical voice for the company during interactions with Health Authorities, investigators, and external partners.
The Executive Director will build and lead all commercial operations capabilities to support the company's inaugural oncology launch. This includes overseeing forecasting, analytics, field effectiveness, and cross-functional launch readiness planning.
The Executive Director will lead the development and execution of the U.S. market access strategy for the company's first commercial oncology launch. They are responsible for building the market access organization and overseeing pricing, reimbursement, patient support, and distribution operations.
The Executive Director will lead and manage the Global Medical Affairs team to develop and execute oncology portfolio strategies. They will collaborate cross-functionally to ensure effective communication of scientific data and maintain relationships with key opinion leaders.
